Universal flu vaccine trial shows promise in early human testing
NCT ID NCT05901636
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 31 times
Summary
This study tested a new universal influenza vaccine in 170 healthy adults aged 18 to 45. The goal was to see if the vaccine is safe and triggers an immune response against many flu strains. Participants received either the vaccine or a placebo, and researchers monitored side effects and antibody levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA PREVENTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CTI Clinical Trial and Consulting Services
Cincinnati, Ohio, 45212, United States
-
Clinical Trials Managements, LLC
Metairie, Louisiana, 70006, United States
-
Floridian Clinical Research LLC
Miami Lakes, Florida, 33016, United States
-
Johnson County Clin-Trials
Lenexa, Kansas, 66219, United States
Conditions
Explore the condition pages connected to this study.